In this episode, we delve into Nvidia's substantial $50M investment in Recursion, a leading firm in AI drug discovery. We'll explore the strategic implications of this partnership, discuss how it might accelerate the application of AI in pharmaceutical research, and consider its potential to revolutionize drug discovery. Get on the AI Box Waitlist: https://AIBox.ai/ Investor Contact Email: [email protected] Sponsor the Podcast: [email protected] Facebook Community: ⁠https://www.facebook.com/groups/739308654562189/⁠ Discord Community: https://aibox.ai/discord Download Selfpause: https://selfpause.com/Podcast ⁠Inflection AI Report⁠ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related